SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
XLV Analysis & Videos »
XLV: Bull or Bear?
ProActive HavRx Stock Indexes
XLV
|
|
|
+4.11%
in
20 days
Below are descriptions of the 20 ProActive HavRx global equity indexes that include a database of over 1,000 stocks with links to the Investars YOU website for performance tracking. http://www.proactivenewsroom.com/indexes/ ImmunoTherapy / Vaccines Index <> The actively managed HavRx ImmunoTherapy / Vaccines Index includes companies with market caps below $5 billion at the time of index inclusion which are developing or commercializing any type of immunotherapy, gene therapy, or vaccine product that is designed to stimulate the immune system for the eradication, ...
|
New Indexes to Track Healthcare Trends and More
XLV
|
|
|
+0.77%
in
46 days
(closed on 10/23/09)
<font> Below are links and descriptions for stock indexes I have created, revised, and tracked over the past few years which are now featured at the website Investars YOU. This site includes automated index tracking and allows investors to link their brokerage accounts to create custom stock portfolios based on their individual preferences from the stock indexes at the site. </font> <font> http://www.mikehavrx.com/2009/09/new-indexes-to-track-healthc... </font> <> <font> However, unregistered users have the ability to generate stock ideas from any of the free indexes (including...
|
BioMedReports.com: Contributing Authors Wanted
XLV
|
|
|
+10.71%
in
102 days
(closed on 06/26/09)
We are looking for contributing authors to submit articles for publication at BioMedReports.com; so if you are interested please contact me or use the online article submission link below: <> Currently, there is no monetary compensation for articles which are chosen for publication, but this may change in the future as our site grows and we may choose to pay the top contributing authors on a freelance basis per published article. Along with your first article submission, please include yo...
|
Three Oversold Healthcare Catalyst Stocks
XLV
|
|
|
+7.54%
in
4 days
(closed on 03/16/09)
Three Oversold Healthcare Catalyst Stocks With the S&P 500 SPDR ETF (SPY) trading about 8% below its 50-day moving average (DMA), I went in search of oversold healthcare stocks trading at least 16% below their 50 DMA which have potential catalysts within the next six months that may provide some very nice returns. <> The Healthcare Sector SPDR (XLV) is trading about 12% below its 50 DMA amidst concerns of sweeping healthcare reform that would threaten the profits of health insurers, managed care companies, big pharma, and biotechs – although such concerns may be ove<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>...
|
New Website for Healthcare Investors and Traders
XLV
|
|
|
-16.64%
in
30 days
(closed on 03/12/09)
<> A new website for healthcare investors and traders should be ready to launch by the end of February, which is designed to provide users with more features beyond my current blog format.
The site will feature its own blog, discussion forum, news feeds, videos, stock commentaries (including multiple contributors), and other unique content – including my FDA and Clinical Trial Calendars plus a database that includes hundreds of foreign and U.S.-listed stocks in the healthcare sector which are organized into unique indexes, including:
1....
|
New Website for Healthcare Investors and Traders
XLV
|
|
|
-3.10%
in
4 days
(closed on 02/10/09)
<> Stay tuned for more details and web links for a new website for healthcare investors and traders, which is designed to provide users with more features beyond my current blog format.
The new site will feature its own blog, discussion forum, news feeds, videos, stock commentaries (including multiple contributors), and other unique content – including my FDA and Clinical Trial Calendars plus a database that includes hundreds of U.S.-listed stocks in the healthcare sector which are organized into unique indexes such as the Emerging Stem Cell Ind< />< /><><><>< />< /><>< />< /><><>< />< /><><>< />< />< />< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><><>...
|
One Year Analysis of Healthcare ETFs
XLV
|
|
|
+5.95%
in
15 days
(closed on 02/06/09)
<> The table at my website link below includes a summary and statistics for the 25 healthcare exchange-traded funds (ETFs) which are currently on the market. The group posted a 23.5% loss over the past year on an equal-weight basis with an average of about $400M in net assets. However, the top eight ETFs by net assets account for 88.5% of all net assets for the entire group of 25, including Healthcare Sector SPDR (XLV), Pharma HOLDRs (PPH), iShares Nasdaq Biotech (IBB), Biotech HOLDRs (BBH), iShares Dow Jones U.S. Healthcare (IYH), iShares S&P Global Healthcare (IXJ), Vanguard Healthcare (VHT...
|
Create Your Own Diagnostics ETF
XLV
|
|
|
+0.43%
in
2 days
(closed on 01/22/09)
Create Your Own Diagnostics ETF <> With HealthShares closing shop at year-end , including the former Diagnostics fund, investors who are interested in the space can create their own ETF comprised of companies from the ETF Innovators Preventive Medicine and Emerging Diagnostics Indexes. Below is a list of companies which have stocks listed for trading in the U.S. at over $1/share with a market cap of less than $10B, focusing on smaller companies which are more leveraged to diagnostics and represent possible takeover targets for larger players such as Roche (...
|
Beyond Active ETFs: Build Your Own
XLV
|
|
|
-1.38%
in
2 days
(closed on 01/20/09)
<> Index Universe reported last week that Grail Partners has requested SEC approval to launch two new exchange-traded funds (ETFs) which are actively managed and do not track an underlying index. The Grail American Beacon Large Cap Value ETF and the Grail American Beacon International Equity ETF would not have any restrictions on trading, but Grail expects to provide more details on target turnover rates for the funds once the managers and investment strategy is in place.
As an alternative investing strategy, why not create your ow...
|
ETF Innovators: 24 New Product Ideas
XLV
|
|
|
+0.00%
in
23 hours
(closed on 01/18/09)
ETF Innovators: 24 New Product Ideas Below are 24 new exchange-traded product (ETP) ideas, which are organized by the following sectors and themes: transports (six), healthcare (11), Non-Healthcare (five), and commodities (two). The 20 stock-based ETF ideas below are structured as semi-active indexes with monthly rebalancing to choose the top rated stocks as active components on an equal-weight basis. <> Most of the ideas represent first-to-market ideas and several such as Air and...
|
A New Global Healthcare Composite Index
XLV
|
|
|
+1.24%
in
4 days
(closed on 01/17/09)
<> 
The accompanying table [click to enlarge] presents the top five rated companies with market caps of at least $100M from each of the eight new ETF Innovators healthcare indexes, including a database exceeding 500 companies worldwide. The Healthcare Composite Index is a dynamic, semi-active index with quarterly rebalancing which consists of the 40 top-rated companies on an equal weight basis from each of the eight global healthcare indexes listed below and represents an alternative strategy to existing health composite ETF...
|
Healthcare ETFs Outpace the Market
XLV
|
|
|
-3.22%
in
72 days
(closed on 01/13/09)
<> 
The accompanying table presents an analysis and statistics for the 28 healthcare ETFs listed at the Yahoo! Finance ETF Center. As a group, the healthcare ETFs outpaced the overall market in the past year by more than 10%, posting an average loss of 26.5% compared to a loss of 37.4% for the S&P 500 SPDR ETF (SPY). The best performing healthcare ETF was the Biotech HOLDRs (BBH), thanks to a buyout bid for top holding Genetech (DNA) and solid earnings results this year for the number two position, Amgen (AMGN).
The top three...
|
Health IT Poised to Rebound on Prospects for Increased Spending
XLV
|
|
|
+0.15%
in
2 days
(closed on 11/01/08)
<> 
As I wrote previously, both presidential candidates are bullish on the healthcare information technology industry – planning to increase spending and investment as a way to improve the quality of healthcare and reduce costs through automation and the widespread implementation of other technologies such as electronic prescribing and computerized medical records. The accompanying tables highlights the performance over the past year of the ETFI Health IT Index of 38 companies along with the top five < />< />< />< />...
|
An Earnings Encore for Amgen?
XLV
|
|
|
+1.22%
in
8 days
(closed on 10/30/08)
<> 
I think Amgen (AMGN) will beat consensus estimates for sales and profits again today when it reports after the market close, continuing the same trends as last quarter, including better than expected sales of embattled anemia drugs Aranesp and Epogen. Amgen reported 2Q08 results (see conference call transcript ) that beat consensus analyst estimates and raised its full-year [FY] guidance for earnings and revenue, thanks to much stronger-than-expected sales of its anemia drugs Aranesp and Epogen:
- 2Q08 Revenue +1% at $3.8 bi...
|
People Bullish on XLV
People Bearish on XLV
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Be the first to start a discussion and earn 2 points.
More Resources
|
About Select Sector SPDRHealth Care
- Answers.com
